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Introduction: Bronchopulmonary dysplasia (BPD) is a multifactorial chronic lung disease that contributes 
to disruption of pulmonary development. It may impair   pulmonary function in early childhood and 
persist throughout school-age, adolescence, and into adulthood.
Objective: To analyze, through a systematic review, the impact of BPD on pulmonary function in early 
childhood. 
Methods: Systematic searches were performed in three electronic databases (Medline, SciELO and 
PEDro). Two independent examiners analyzed the titles, abstracts and full texts, considering the 
following study inclusion criteria: studies of pulmonary function in up to 5-year-old children diagnosed 
with BPD in the neonatal period.
Results: Initially, 1789 articles were identified, and the final sample included 22 articles. It could be 
observed that children diagnosed with BPD in early childhood showed expiratory flow limitation and 
reduced functional residual capacity. However, pulmonary function in children with a history of BPD 
remains reduced when compared with healthy full-term children. Moreover, there are no positive 
responses in pulmonary function values  with the use of bronchodilators.
Conclusion: Children with BPD show changes in pulmonary function, which may improve with growth, 
and most of them do not respond positively to bronchodilators.
Keywords: bronchopulmonary dysplasia, lung diseases, infant, respiratory function testing, child.
 INTRODUCTION
Neonatal chronic lung disease, also known as bron-
chopulmonary dysplasia (BPD), is defined as the need for 
respiratory support with oxygen and/or mechanical ven-
tilation in the first 28 days of life1-4. Children who devel-
oped the disease in the postnatal period may show abnor-
malities in pulmonary function5.
Currently, pulmonary function testing in early 
childhood, i.e., the  time period ranging from 0 to 6 years 
including infants and preschoolers, can be performed by 
examinations, such as rapid chest compression, single 
breath occlusion, plethysmography and helium dilution6. 
Studies indicate that infants with BPD show compromised 
pulmonary function in the first years of life, with signifi-
cant expiratory flow limitation, namely, forced expiratory 
volume in one second (FEV1), mean forced expiratory 
flow (FEF25-75%), as well as reduced pulmonary compli-
ance, increased pulmonary resistance, higher respiratory 
rate, reduced functional residual capacity (FRC) and re-
sidual volume7-24. 
These results are characteristics of ventilatory and 
functional changes, the knowledge of which may provide 
a better understanding of the disease and, consequently, 
improve treatment and preventive strategies to manage the 
disease. Therefore, this study aimed to analyze the impact 
of bronchopulmonary dysplasia on the pulmonary func-




The literature review strategy included electronic search-
ing using three bibliographic online databases: SciELO 
(Scientific Electronic Library Online), PEDro (Physio-
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 RESULTS
A total of 1789 articles were identified, 61 titles of 
which were selected for analysis of their respective abstracts. 
Next, 33 articles were shortlisted for full review, and 11 were 
excluded because they did not meet the inclusion criteria. The 
final sample consisted of 22 articles as shown in the flowchart 
(figure 2).
Of the 22 articles included (table 1), 12 assessed 
children with a history of BPD at different moments (longi-
tudinal)7-16,27,28 and the maximum follow-up was the interval 
between the neonatal hospital stay and five years of life. The 
remaining ten reviewed studies performed pulmonary func-
tion testing in one single moment (transversal).17-22,29-32 
therapy Evidence Data base) and Medline (Medical Liter-
ature Analysis and Retrieval System Online via Ovid. The 
publications were selected until the date of online search-
ing, i.e., September 2016, regardless of the language. 
The authors developed a search strategy for Medline (via 
OVID web) and PEDro, which are shown in (Figure 1), 
due to the absence of this type of publication on the topic. 
The following keywords were used for the SciELO data-
base: displasia broncopulmonar, bronchopulmonary dys-
plasia.
Selection Strategy
The articles were screened by 2 examiners, who 
independently analyzed the results of the online search for 
potentially eligible articles. The publications which met 
all previously established inclusion criteria were selected, 
and doubtful cases were discussed. First, the reviewers 
read the titles, followed by an analysis of the abstracts. 
Medline (ovid web)
1. Randomized controlled trials as topic/ 
2. Randomized controlled trial/
3. Random allocation/
4. Double blind METHODS/ 
5. Single blind method/
6. Clinical trial/
7. Exp clinical trials as topic/
8. (Clinic* adj trial*1).Mp.
9. ((Singl* or doubl* or tripl*) adj (blind*3 or mask*3)).Mp. 
10. Placebos/
11. Placebo*.Mp.
12. Randomly allocated.Mp. 
13. (Allocated adj2 random).Mp. 
14.  1 Or 14 
15. Bronchopulmonary dysplasia/
16. Pulmonary dysplasia
17. Infant, premature, diseases/
18. Respiratory distress syndrome newborn/
19. Respiratory system abnormalities/
20. Pulmonary fibrosis/
21. Or/17-22
22. Lung volume measurements/
23. Respiratory function tests/







The studies that proved to be eligible were reviewed in 
full,  in agreement with the recommendations of the Main 
Items for Reporting Systematic Reviews and Meta-analy-
sis (PRISMA)25,26 (Figure 2).
Analysis of data
Inclusion criteria were: clinical trials that 
assessed pulmonary function of infants and pre-
school children aged 0-4 years with a diagnosis 
of BPD in the neonatal period. The diagnosis of 
BPD was defined as the need for supplemental ox-
ygen above 21% during 28 days or more.24 Stud-
ies that were not available through the Program 
Manager Bibliographic Commuting (Comut), the 
newspaper ’s website or Ovid database, were not 
used for analysis.newspaper ’s website or Ovid 
database, were not used for analysis.
31. Or/24-32
32. Infant, newborn/









42. 16 and 23 and 33 and 43
PEDro
Strategy 1
Field Title/abstract: Bronchopulmonary dysplasia
Field Therapy: respiratory therapy
Field METHODS: clinical trial
Field Problem: No appropriate
Strategy 2 
Field Title/abstract: Bronchopulmonary dysplasia
Field Therapy: respiratory therapy
Field METHODS: clinical trial
Field Problem: impaired ventilation
SciELO
Displasia broncopumonar or bronchopulmonary
dysplasia [all indexes]
Figure 1: search strategy
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Figure 2: Flowchart showing selection of articles for review (adapted from Moher et al. 2009)
 
Total of titles after duplicate removed (n = 1739)
Full-text articles assessed 
for eligibility 
(n = 33)




Other type of disease (3)
Titles identified through other 
sources – manual search (n =4)
Titles identified through data-
base search (n = 1785)
Total assessed titles
 (n = 1739)
Articles excluded based on the titles 
(n =1678)
(Topic not reported, experimental study, 
reviews, meta-analysis, pilot studies, case 
studies)
Abstracts screened             
(n = 61)
Articles excluded based 
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Table 1: Summary of articles selected for systematic review
ResultsAuthor, Year
Tepper et al., 1986
Hjalmarson et al., 2005 
Farstad et al.,1995
Schmalisch et al., 2005 
Filbrun et al., 2011
Baraldi et al., 1997 
Schmalisch, 2012.
Boeck et al.,1998
Pérez et al., 1999
Robin et al.,  2004
Thunqvist et al.,  2014
May et al., 2011
Balinotti et al., 2010
Mahut et al., 2007
Mallory et al., 1991
Vural et al., 1996
Khoulood et al., 2010
Vrijlandt et al., 2007
Greenough et al., 2005
Kavvadia et al., 1998
Wei et al., 2013
Fouzas et al., 2013
Compared to CG, BPDG had lower FRC up to 10.5 months of PCA; BPDG showed decreased 
corrected and absolute expiratory flows compared to CG. The linear regression slope of the VMA-
XFRC x length was lower in BPDG, indicating low AWs growth.
Severe BPD showed reduced FRC, less efficient gas mixture and higher specific conductance, 
compared with CG, mild and moderate BPD.
RSR was higher in BPDG than in CG with 50 weeks of CA, but decreased with 120 weeks. Analysis 
of the VMAXFRC showed that 80% of the children with BPD and 58% of CG had severe peripheral 
obstruction with 50 weeks; no controls with 120 weeks (p <0.05) and 38% BPDG with severe 
obstruction.
Differences between children with BPD and CG were found during tidal breathing of 0.45 vs 0.65; 
RR: 55.4 vs 39.2. 
In the first evaluation, FEV0.5, FEV75, FEV 25-75 showed significant reduced values. In the re-
-evaluation, mean lung volume and flow remained close to the initial values, below the predicted, 
indicating lack of pulmonary growth. Children with above-average growth showed improved FVC, 
FEV0.5, TLC, and RV/TLC.
Severe changes in the mechanical properties of the RSR lung were found during the acute phase 
of BPD. The progressive improvement occurred from 3 months. At 24 months of age, RSR rea-
ched the normal range.
There was no significant difference between the groups regarding RR, TRR and AWs, or blood gas 
levels. CV, EV, pulmonary compliance and FRC were lower in children with BPD compared to CG. 
However, these differences became non-significant after normalization of body weight.
There was no significant decrease in lung resistance after inhalation of salbutamol or ipratropium 
bromide in patients with BPD.
Mean values for compliance and RSR were within normal range; mean value for peak expiratory 
flow time was below normal, indicating airway obstruction.
BPDG showed lower FEV0.5, FEV75, FEV25-75; and FRC, RV, and RV/TLC higher than CG. 
In BPDG, 17 patients underwent a bronchodilator testing and only 6 showed bronchodilator 
response.
Only FRC values and RS compliance at 18 months were not below the normal values; all other 
lung function measurements were significantly below normative values. During follow-up at 6 
and 18 months, NB with respiratory symptoms had lower values of maximum and mean forced 
expiratory peak, and RS compliance value compared to individuals without symptoms.
NB who developed moderate/severe BPD had lower FRC values and compliance over the entire 
28 day period, compared to those who did not develop BPD. The rate of improvement in FRC and 
compliance over the first 28 days was higher in NB with moderate/severe BPD.
Individuals with BPD had a significant decrease in lung diffusion compared to CG subjects. Pul-
monary capacity was significantly lower for individuals with BPD compared to CG.
Most children showed low VmaxFRC values, suggesting an obstructive pattern. Strong correla-
tions were observed between FRC measurements and oxygen exposure.
During the first 6 months of age in both groups, FVC was significantly lower in BPDG, compared 
to normal value. At 24 and 36 months of age, mean FVC was even lower in Group B than in Group 
A, but the difference was not significant.
Significant relationships were found between thoracic distension and duration of positive inspira-
tory pressure (P <0.05, r = 0.43), duration of positive expiratory pressure (P <0.05, r = 0.45), 
total time of oxygen therapy; between total lung resistance and duration of mechanical ventila-
tion with high frequency (P <0.05: r = 0.52); between hypoxemia and time of oxygen therapy 
with FiO 2> -60% (P <0.05; r = 0.54).
Children with BPD had low expiratory airflow at 6, 12, and 24 months, respectively, with no sig-
nificant improvement over time. FRC has increased significantly over time.
The resonance frequency was higher in BPD compared to non-BPD (mean of 26.8 vs 22.7, P 
<0.001) and lower mean reactance X4-24 (hPa.s / l) (- 3.0 vs. -1.9, P< 005).
Children with BPD showed significantly lower pulmonary values, compared with non-BPD children.
 
FRC at 14 and 28 days were lower in group A than in group C (P <0.01). Group B showed lower 
difference (P <0.05) at 28 days, when compared to group C.
In moderate and severe BPD groups, RR was higher than in the non- BPD group. In the BPD 
group, FRC was higher than the moderate and severe groups.
Capnography waveforms in phase II (SII) and III (SIII) were more pronounced in children with 
BPD compared to healthy preterm and full-term infants.
Legend: CG: control group; BPDG: group with bronchopulmonary dysplasia; FRC: functional  residual capacity; PCA: post- conceptional 
age;  AWs: airways; RSR: respiratory system resistance; CA: corrected age; RR: respiratory rate; FEV0.5: forced expiratory volume at half 
second; FEV75:  forced expiratory volume at 75% of curve of forced vital capacity; FEV25-75: forced expiratory volume between 25 and 75% 
curve of forced vital capacity;  FVC: forced vital capacity; TLG: total lung capacity; RV: residual volume; RV/TLC: residual volume and total 
lung capacity ratio; TRR: total respiratory resistance;  CV: current volume; EV: expiratory volume;  RS: respiratory system; NB: new-born; 
FiO2: fraction of inspired oxygen.
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 DISCUSSION
Notably, maintaining the integrity of the respira-
tory system in the first two years of life is essential and will 
determine the improvement of gas exchange and respiratory 
reserve after infancy33 as this is the period of greatest alveo-
lar growth34. In this review, the studies suggest that respira-
tory symptoms and pulmonary function seem to improve in 
early childhood7,8,10,12,27 with the growth and development of 
the child with a history of BPD. Farstad et al.12 found that, at 
50 weeks of corrected age (CA), 80% of the children with 
BPD in their study sample had severe peripheral obstruc-
tion, compared to 58% of preterm infants without BPD. In 
the reevaluation period (120 weeks of CA), only 38% of 
the children with BPD presented with severe obstruction 
versus no preterm children. According to Sanchez et al.35 
the progressive improvement of capacity and flow-volume 
curves in this population is proportional to the increase in 
weight and length of infants. On the other hand, Hjalmarson 
et al.13 observed that the pulmonary function in infants us-
ing bronchodilators remains reduced even after normaliza-
tion of weight, compared to healthy infants. However, these 
alterations may not be significant considering the normal 
values of pulmonary function parameters12,17. In this con-
text, some authors7,8,10 point out that improved pulmonary 
function during infancy is more evident in children with 
moderate/severe BPD, compared to those with mild BPD, 
or in preterm infants without BPD28.
It is well-established that some complications 
caused by BPD in early childhood may favor high rates 
of respiratory infections, recurrent wheezing and hospital 
readmissions12,28,33,34,36. According to a study conducted by 
Tepper et al.14 55% of infants with BPD required prehospi-
talization during the first year of life due to diseases of the 
lower respiratory tract. The incidence of respiratory mor-
bidity and prehospitalization has been lower in healthy full-
term infants28, as well as in preterm infants who developed 
respiratory distress syndrome12 when compared to infants 
with bronchopulmonary dysplasia . However, Mahut et al.29 
observed that there is no difference in pulmonary function 
among BPD infants with frequent symptoms and those with 
fewer or no symptoms, and all of them showed reduced 
FRC. These results suggest that pulmonary function as well 
as other factors may be involved in the high susceptibility 
to respiratory infections in this population.
Another topic identified in the current review is the 
response of BPD children to bronchodilators. The selected 
studies demonstrate no reduction in inspiratory and expi-
ratory resistance after the use of bronchodilators in most 
children with a history of BPD. 
Children who respond to these medications show 
greater abnormalities in pulmonary function parameters 
than non-responders22,32. According to Fakhoury et al.23 up 
to 3 years of age, only 20 to 30% of children with moder-
ate to severe BPD show bronchodilator response. There-
fore, this drug should not be indicated for all patients with 
BPD, but only for responders or patients show worsening in 
wheezing during acute respiratory exacerbation22,32.
Current articles and reviews have shown limited 
pulmonary function, functional capacity and quality of life 
of schoolchildren37 and adults38 with BPD. However, the 
impact of BPD on infants and preschool children has not 
been often discussed. This review was able to collect results 
of current studies about the disease in this age group.  A 
limitation of this review is the lack of classification of the 
methodological quality, by means of valid instruments.
In summary, children with a history of BPD usually 
show alterations in pulmonary function in the first three 
years of life, which seems to improve with growth and 
become non-significant after body weight adequacy. How-
ever, when comparing BPD children with full-term chil-
dren, this limitation can still be observed. Also, most BPD 
children do not show positive response in pulmonary func-
tion after the use of inhaled bronchodilator. But, responders 
have compromised pulmonary function.
Admittedly, there is a gradual improvement of pul-
monary function in the first years of life. Therefore, public 
health professionals involved in the care of this population 
should consider the importance of nutritional aspects and 
prevention of respiratory infections in this period, in order 
to allow conditions for adequate pulmonary growth and 
development. This may attenuate alterations in pulmonary 
function due to neonatal injury. Furthermore, early identifi-
cation of possible impairment of pulmonary function may 
help pediatricians and/or pulmonologists to prevent disease 
complications by means of strategies, e.g., to encourage 
children to keep regular physical activities as soon as pos-
sible, and to refer patients for physical therapy as a preven-
tive measure or during acute respiratory events.
 CONCLUSION
It could be observed that children diagnosed with BPD 
during the neonatal period showed expiratory flow limita-
tion and reduced FRC when assessed in early childhood, 
compared to healthy full-term and preterm children. Most 
children show improved values of pulmonary function with 
growth and normalization of weight.
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Resumo
Introdução: A displasia broncopulmonar (DBP) é uma doença pulmonar crônica multifatorial que 
interrompe o desenvolvimento pulmonar, podendo repercutir em comprometimento da função pulmonar 
na primeira infância, que pode perdurar durante a idade escolar, adolescência, até a idade adulta.
Objetivo: Analisar, através de uma revisão sistemática, as repercussões da DBP na função pulmonar 
de crianças na primeira infância.
Método: Foram realizadas buscas sistematizadas em três bases de dados eletrônicas (Medline, SciELO 
e PEDro). Dois examinadores independentes analisaram sistematicamente os títulos, resumos e textos 
na íntegra, considerando os seguintes critérios de inclusão: estudos que avaliaram a função pulmonar 
de crianças com até 5 anos de idade que apresentaram diagnóstico de DBP no período neonatal.
Resultados: Inicialmente foram identificados 1789 artigos, sendo que a amostra final foi composta de 
22 artigos. Evidenciou-se que crianças com DBP apresentam na primeira infância limitação dos fluxos 
expiratórios e redução da capacidade residual funcional. Estas alterações podem ser normalizadas 
ou minimizadas com o crescimento e adequação de peso, porém, a função pulmonar das crianças 
com história de DBP continua reduzida em comparação a crianças hígidas nascidas a termo. Ainda, 
a maioria delas não apresenta respostas positivas nos valores de função pulmonar com o uso de 
broncodilatadores.
Conclusão: Crianças com DBP apresentam alterações na função pulmonar, podendo melhorar com o 
crescimento, sendo que a maioria não responde positivamente ao broncodilatador.
Palavras-chave: displasia broncopulmonar, doenças pulmonares, lactente, testes de função 
respiratória, criança.
